ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1216

Risk Factors Associated With Fracture Occurrence Appear to Differ Between Distal Radius, Clinical Vertebral, and Hip Fractures in Japanese Patients With Rheumatoid Arthritis: A Prospective Observational Cohort Study

Kensuke Ochi1, Takefumi Furuya1, Yuki Go1, Eisuke Inoue2, Katsunori Ikari1, Atsuo Taniguchi2, Hisashi Yamanaka1 and Shigeki Momohara2, 1Institute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan, 2Institute of Rheumatology, Tokyo Women’s Medical University, Tokyo, Japan

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Fracture risk, glucocorticoids and rheumatoid arthritis (RA), Health Assessment Questionnaire, Japanese

  • Tweet
  • Email
  • Print
Session Information

Title: Osteoporosis and Metabolic Bone Disease: Clinical Aspects and Pathogenesis

Session Type: Abstract Submissions (ACR)

Background/Purpose: Patients with rheumatoid arthritis (RA) are at high risk of developing fractures. Previously, utilizing data from our Institute of Rheumatology Rheumatoid Arthritis (IORRA) cohort study, we reported clinical risk factors for clinical vertebral and any nonvertebral fractures in women [1] and men [2] and hip fractures [3] in Japanese patients with RA . However, we did not evaluate the risk factors for distal radius fractures alone, because in our previous studies, the number of distal radius fracture patients was small. In this study, we evaluated the association between potential risk factors and the occurrence of distal radius fractures and compared the risk factors for clinical vertebral, any nonvertebral, and hip fractures in Japanese patients with RA [1-3].

Methods: IORRA is a prospective observational cohort study of Japanese patients with RA at the Institute of Rheumatology, Tokyo Women’s Medical University that was established in 2000. A total of 9,987 patients (82.0% female; mean age, 55.7 years) with RA were enrolled in a prospective, observational study from 2000 to 2011. Self-reported distal radius fractures were verified using patient medical records. Cox proportional hazards models were used to analyze independent contributions of various risk factors to distal radius fracture occurrence.

Results: During a mean follow-up period of 5.7 years, 139 patients reported 153 distal radius fractures. Among these patients, 85 distal radius fractures in 85 patients (6 men, 79 women) were verified by medical records. The multivariate Cox regression analyses estimated that the hazard ratios of sustaining a distal radius fracture increased by 15.27 for female gender [95% confidence interval (CI), 1.96-119.02], 1.60 for every 10 years of increased age (95% CI, 1.15-2.22), 1.11 for body mass index (BMI) (kg/m2, 95% CI, 1.01-1.22), and 1.09 for daily prednisolone dose (mg, 95% CI, 1.01-1.18). Unlike risk factors for clinical vertebral, any nonvertebral, and hip fractures evaluated using data from this same cohort [1-3], no significant association was observed between the occurrence of distal radius fractures and Japanese health assessment questionnaire (J-HAQ) disability score (Table). A high BMI was a risk factor for distal radius fractures, whereas a low BMI was a risk factor for hip fractures [3] (Table).

Conclusion: Female gender, advanced age, high BMI, and high daily prednisolone dose appear to be associated with the occurrence of distal radius fractures in Japanese patients with RA. Risk factors appear to be different between distal radius, clinical vertebral, any nonvertebral, and hip fractures in Japanese patients with RA.

Table Risk factors for fractures in Japanese patients with RA

Risk factors Fractures Clinical vertebral

Any nonvertebral

Hip Distal radius
Advanced age Yes [1] Yes [1, 2] Yes [3] Yes
Female gender ND ND NS [3] Yes
J-HAQ disability score Yes [1,2] Yes [1] Yes [3] NS
Body mass index (BMI) NS [1,2] NS [1,2] Low BMI [3] High BMI
Daily prednisolone dose Yes [2] NS [2] NS [3] Yes
History of orthopedic  surgery for RA Yes (any) [1] Yes (TKR) [2] Yes (TKR) [3] ND

ND, not determined; NS, not significant; TKR, total knee replacement

References: 1) Furuya T, et al. J Rheumatol 34: 303-310, 2007; 2) Furuya T, et al. J Bone Miner Metab 26: 499-505, 2008; 3) Furuya T et al. Osteoporos Int 24: 1257-1265, 2013


Disclosure:

K. Ochi,
None;

T. Furuya,
None;

Y. Go,
None;

E. Inoue,
None;

K. Ikari,
None;

A. Taniguchi,
None;

H. Yamanaka,

Abbott, AbbVie, Asahikasei , Astellas, AstraZeneca, Bristol-Myers Squib, Chugai, Daiichi Sankyo, Eisai, GlaxoSmithKline, Janssen, Mitsubishi Tanabe, MSD, Nippon Kayaku, Pfizer, Santen, Taishotoyama, Takeda, Teijin,

2,

Abbott, AbbVie, Astellas, AstraZeneca, Bristol-Myers Squib, Chugai, Daiichi Sankyo, Eisai, Mitsubishi Tanabe, Nippon Kayaku, Pfizer, Takeda, Teijin,

5,

Abbott, AbbVie, Astellas, Bristol-Myers Squib, Chugai, Eisai, Mitsubishi Tanabe, Pfizer, Takeda, Teijin,

8;

S. Momohara,
None.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/risk-factors-associated-with-fracture-occurrence-appear-to-differ-between-distal-radius-clinical-vertebral-and-hip-fractures-in-japanese-patients-with-rheumatoid-arthritis-a-prospective-observ/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology